Market brief
Treasury yields dive; Amex, Bloom Energy results – Market Brief, Oct 23, 2026
Published Oct 23, 2026
Treasury yields posted their biggest drop since 2023 as tech slid, while American Express and Balchem filed results and Bloom Energy beat estimates.
Takeaway: The day's main thread was a split market: Treasury yields fell by the most since the 2023 banking turmoil while technology and artificial-intelligence-linked shares slumped, even as most of the S&P 500 rose. Alongside that, several companies filed quarterly results with the SEC, including American Express and Balchem, and telecom shares were pressured by reports about SpaceX's Starlink mobile plans.
Treasury yields post biggest daily drop since 2023 as tech slides
MarketWatch reported that the yield on the 10-year Treasury note recorded its largest one-day fall since the collapse of Silicon Valley Bank in 2023, with Treasurys rallying while technology stocks slumped. More than 300 S&P 500 members rose on Thursday even as the AI-linked trade weakened, and CNN's Fear & Greed gauge was pointing to fear. One report described an unusual market-breadth event that it said has occurred only once before since 1999. A bond manager quoted by MarketWatch called the move a 'take-back trade' rather than an outright recession scare.
Why it matters. Bond yields move opposite to bond prices, so a sharp yield drop means investors paid up for government debt. The split between falling tech shares and rising shares elsewhere may suggest money is rotating between parts of the market rather than leaving it, though the sources do not settle whether the shift signals slower growth ahead.
Sources: MarketWatch · MarketWatch (2) · MarketWatch (3) · MarketWatch (4)
American Express files quarterly results with the SEC
American Express filed an 8-K with the SEC under Item 2.02, the section used to disclose results of operations and financial condition, along with a Regulation FD disclosure and supporting exhibits. The filing itself does not state the figures in the feed item.
Why it matters. An Item 2.02 filing is how a company formally puts its earnings release on the public record. Because American Express both lends to and processes payments for cardholders, its results may be read for signals about consumer spending and credit quality, but the filing summary here contains no numbers to judge that.
On this site: AXP Q2 2026 analysis
Sources: SEC EDGAR (8-K)
Telecom shares fall on reports of Starlink talks with tower owners
MarketWatch reported that shareholders of Verizon, AT&T and T-Mobile reacted badly to reports that SpaceX's Starlink unit has been in discussions with cell-tower owners, the latest step in the satellite operator's mobile ambitions.
Why it matters. Satellite-based mobile service could compete with, or change the economics of, traditional wireless networks. Nothing in the report confirms a completed deal, so any effect on the carriers' businesses is speculative. For context, the site's latest figures for AT&T show Q3 2026 revenue of $32.3B, up 5.3%, with EPS of $0.13.
On this site: T Q3 2026 analysis · VZ Q2 2026 analysis
Sources: MarketWatch
Bloom Energy tops estimates but shares stay in a rut
MarketWatch reported that fuel-cell maker Bloom Energy, which has benefited from data-center demand, beat earnings expectations by 36% and revenue expectations by 15%, yet did not get the share-price lift that such a result would normally bring.
Why it matters. When a company clears forecasts and the stock still does not rise, it may mean investors had already priced in strong growth or are rethinking how much they will pay for AI- and data-center-linked businesses, which fits the broader pullback in that part of the market reported the same day.
Sources: MarketWatch
Balchem and BayCom file quarterly earnings disclosures
Balchem filed an 8-K with the SEC disclosing results of operations and financial condition with accompanying exhibits. Community lender BayCom Corp made a similar Item 2.02 filing. Neither feed item includes the underlying figures.
Why it matters. These filings put the quarters formally on record for two smaller companies. For reference, the site's last published figures were Balchem Q2 2026 revenue of $284M, up 11.2%, with EPS of $1.39, and BayCom Q2 2026 net interest income of $24M with a net interest margin of 3.95% and a loss of $0.64 per share. Net interest margin is the gap between what a bank earns on loans and pays on deposits.
On this site: BCPC Q2 2026 analysis · BCML Q2 2026 analysis
Sources: SEC EDGAR (8-K) · SEC EDGAR (8-K) (2)
Lunai Bioworks discloses listing-standard notice and officer changes
Lunai Bioworks filed an 8-K reporting a notice of delisting or failure to meet a continued listing rule or standard, together with a change involving directors or officers.
Why it matters. A continued-listing notice means an exchange has told a company it no longer meets one of the requirements to keep its shares listed. The filing summary does not say which standard is at issue or what the company plans to do, so the outcome is unknown.
On this site: LNAI Full Year 2026 analysis
Sources: SEC EDGAR (8-K)
What to watch next
- Moody's is scheduled to update its rating on France's government debt after the U.S. market close on Friday.
- Full earnings details from the American Express, Balchem and BayCom 8-K exhibits.
- Whether the move out of AI-linked shares and into Treasurys continues in coming sessions.
- Any confirmed agreement between Starlink and cell-tower owners after this week's reports.
This brief is compiled from public feeds (official releases, SEC filings and financial press headlines). It paraphrases and links to each source and may miss context in the full articles, so check the linked sources before relying on it. For information only; not investment advice.
Related analyses
- AT&T (T) · Q3 2026Revenue $32.3B (+5.3%) · EPS $0.13 (-89.9%)
AT&T grew Q3 2026 revenue 5.3% to $32.3 billion with its best service revenue growth in over four years and a record 769,000 internet net adds, but a $2.6 billion Mexico write-down cut diluted EPS to $0.13; adjusted EPS rose to $0.65 and 2026 guidance was raised.
- Lunai Bioworks Inc. (LNAI) · Full Year 2026Revenue $52K · EPS -$1.06
Lunai Bioworks' FY2026 net loss shrank 98% to $3.56M, but mostly on accounting items; with $1.71M of cash, $18.97M of liabilities and under a month of funding left, the auditor flagged going-concern doubt.
- Balchem Corporation (BCPC) · Q2 2026Revenue $284M (+11.2%) · EPS $1.39 (+18.8%)
Balchem posted record Q2 2026 sales of $284.0M (+11.2%) and EPS of $1.39 (+18.8%), led by volume growth in Human Nutrition & Health and a 49% profit jump in Animal Nutrition, while inventory rose 23% in six months.
- BayCom Corp (BCML) · Q2 2026Net interest income $24M (+2.5%) · NIM 3.95% · EPS -$0.64
BayCom swung to a $7.0M Q2 2026 loss ($(0.64)/share) on $10.5M of executive-departure costs, while its net interest margin widened to 3.95% and nonperforming loans fell to 0.47%.
For information only; not investment advice.